Nektar Therapeutics (NKTR) Accumulated Expenses (2010 - 2026)
Nektar Therapeutics (NKTR) posted Accumulated Expenses of $23.39 million for Q2 2026, down 33.4% from $35.1 million a year earlier and down 7.0% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, Nektar Therapeutics' Accumulated Expenses came in at $22.27 million, down 25.7% from FY2024.
- Annual Accumulated Expenses shows a three-year compound annual growth rate of -15.2% (FY2022 to FY2025).
- In prior years, Nektar Therapeutics' Accumulated Expenses was $29.97 million in FY2024 (+35.2%), $22.16 million in FY2023 (-39.4%) and $36.56 million in FY2022.
- Quarterly Accumulated Expenses has run from a low of $22.16 million in Q4 2023 to a high of $37.41 million in Q1 2023 over five years.
- On a year-over-year basis, Accumulated Expenses has declined in each of the last four quarters, with growth averaging 0.2% over the last eight quarters.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q4 2024, with growth of 35.2%; the weakest was Q4 2023, with a decline of 39.4%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $25.15 million (Q1 2026), $22.27 million (Q4 2025) and $28.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Nektar Therapeutics | 1.55 Bn | -215.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.39 Mn |
| Mar 31, 2026 | 25.15 Mn |
| Dec 31, 2025 | 22.27 Mn |
| Sep 30, 2025 | 28.59 Mn |
| Jun 30, 2025 | 35.10 Mn |
| Mar 31, 2025 | 31.25 Mn |
| Dec 31, 2024 | 29.97 Mn |
| Sep 30, 2024 | 32.38 Mn |
| Jun 30, 2024 | 29.51 Mn |
| Mar 31, 2024 | 24.28 Mn |
| Dec 31, 2023 | 22.16 Mn |
| Sep 30, 2023 | 29.73 Mn |
| Jun 30, 2023 | 29.14 Mn |
| Mar 31, 2023 | 37.41 Mn |
| Dec 31, 2022 | 36.56 Mn |
| Mar 31, 2015 | 8.25 Mn |
| Dec 31, 2014 | 6.42 Mn |
| Sep 30, 2014 | 7.76 Mn |
| Jun 30, 2014 | 5.81 Mn |
| Mar 31, 2014 | 6.82 Mn |
API Access
Nektar Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();